Request Quote
Untitled

Scientific Laboratory Equipment for Clinical, Industrial & Research Laboratories

Vaccines Containing Genes Could Offer Advantages in Preventing Infectious Diseases

Aug
10
DSS

Disease Vaccine with GenesVaccines for infectious diseases contain weak or dead proteins or pathogens from the disease-causing microorganisms. The vaccines that fight cancer rely on proteins as well. However, scientists have created a new type of vaccine that contains genes and is expected to offer several advantages over its standard predecessor. After decades of research, genomic vaccines are being used in clinical trials.

How It Works: Protein vs. Genomic Vaccines

Protein-based vaccines deliver weak or dead pathogens into the bloodstream so that the immune system can learn to recognize the antigen proteins on the surface as foreign microorganisms. In some cases, vaccines contain only the antigens. The purpose is to prepare the immune system to take action the next time that the antigens are present. In the treatment of cancer, vaccines contain antibody proteins that improve how the immune system responds.

The new genomic vaccines achieve the same end in a different way. They contain genetic material with coding sequences for the desired proteins of one or more diseases. When the DNA or RNA is injected, it enters cells and stimulates them to produce the target proteins.

What This Means for Preventing Infectious Diseases

Currently, vaccine proteins are made in cell cultures or eggs. By using genetic material in vaccines, manufacturers can make them faster and cheaper. Also, one vaccine can include the genetic codes for multiple proteins. The codes can be changed to address pathogen mutations or if new properties are necessary to fight a disease.

For example, the public health industry modifies the flu vaccine every year. However, their changes don't always match the viral strains that circulate during flu season. With genomic vaccines, they can sequence the genetic material according to the strains that are circulating. Furthermore, the new vaccines can be altered and manufactured quickly when viruses such as Ebola or Zika become more widespread or deadly.

Genomic vaccines allow for passive immune transfer as well. In this twist on vaccinations, antibodies are injected instead of antigens. This works by identifying people whose bodies resist a specific pathogen and then isolating the antibodies that protect them. Scientists can then design gene sequences that stimulate cells to produce the antibodies.

Genomic Vaccines Move Into Clinical Trials

The American government, small and large companies, and academic labs are heavily investing in this technology. In a study, scientists used a messenger RNA vaccine. They encapsulated the Zika virus mRNA in a lipid nanoparticle, and it prompted protective immune system responses in mice and primates.

Several clinical trials are also underway to test the immunogenicity and safety of genomic vaccines. Some of the diseases that they're testing with include

  • avian influenza,
  • breast cancer,
  • Ebola,
  • hepatitis C,
  • HIV,
  • lung cancer,
  • pancreatic cancer,
  • prostate cancer, and
  • Zika.

Working to Improve the Technology and Other Advancements

At the same time, other scientists are trying to improve the technology. They want to find even more efficient ways to insert the genes into cells and make the vaccines more stable in heat. They're also studying nasal administration as an alternative to injection.

Meanwhile, Synthetic Genomics scientists have developed equipment that quickly produces DNA, RNA, viral particles and protein drugs from digitally encoded biological information without human intervention. The prototype digital-to-biological converter requires two or three more years of work before it's commercially available. However, the company hopes that it will allow a desktop instrument to produce complex biological materials on-site. Such technology could further benefit genomic vaccine production in the future.

Leave a comment

You are commenting as guest.

FacebookTwitterDiggStumbleuponGoogle BookmarksRedditNewsvineLinkedIn

Scientific Trends

 
  • Vaccines Containing Genes Could Offer Advantages in Preventing Infectious Diseases

    Vaccines Containing Genes Could Offer Advantages in Preventing Infectious Diseases ,

    Author:
    Aug
    10
    , DSS

    Vaccines for infectious diseases contain weak or dead proteins or pathogens from the disease-causing microorganisms. The vaccines that fight cancer rely on proteins as well. However, scientists have created a new type of vaccine that contains genes and is expected to offer several advantages over its standard predecessor. After decades of research, genomic vaccines are being used in clinical trials.
  • Membraneless Organelles Could Help Scientists Better Understand Incurable Diseases

    Membraneless Organelles Could Help Scientists Better Understand Incurable Diseases ,

    Author:
    Jul
    25
    , DSS

    Princeton University and Washington University engineers have collaborated to create a new way to study the material structure of membraneless organelles and observe how they work. Their research could have a myriad of scientific applications and help scientists better understand incurable diseases such as amyotrophic lateral sclerosis or ALS, Huntington's disease and cancers.
  • Is Patient Organoid Testing the Future of Prescription Medicine?

    Is Patient Organoid Testing the Future of Prescription Medicine? ,

    Author:
    Jul
    12
    , DSS

    Researchers used Organoids to learn how the Zika virus affects developing brains. With that, and other successes they've had working with organoids, researchers believe that they can use organoids to determine whether or not a drug will work on a patient by patient basis. In the cases where this technology is being used in trials, several insurers have started covering expensive prescriptions that would have been denied otherwise.
  • Mycoplasma Contamination: The Problem and Prevention for Grant-Funded Research

    Mycoplasma Contamination: The Problem and Prevention for Grant-Funded Research ,

    Author:
    Jun
    29
    , DSS

    Cell lines are important research tools, and contamination with microorganisms is one of the most common concerns. The cell lines need to be authentic to provide the most reliable results. This is why many grants require researchers to test cell lines for mycoplasma contamination.
 

View More